Acorah Software Products - Accounts Production 18.1.200 false true false true No description of principal activity 25 October 2024 31 October 2025 31 October 2025 16042321 Mr Hytham Dafalla iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16042321 2024-10-24 16042321 2025-10-31 16042321 2024-10-25 2025-10-31 16042321 frs-core:CurrentFinancialInstruments 2025-10-31 16042321 frs-bus:PrivateLimitedCompanyLtd 2024-10-25 2025-10-31 16042321 frs-bus:FilletedAccounts 2024-10-25 2025-10-31 16042321 frs-bus:Micro-entities 2024-10-25 2025-10-31 16042321 frs-bus:AuditExempt-NoAccountantsReport 2024-10-25 2025-10-31 16042321 frs-bus:Director1 2024-10-25 2025-10-31
Registered number: 16042321
HD Clinical Solutions Ltd
Unaudited Financial Statements
For The Year Ended 31 October 2025
HD Clinical Solutions Ltd
Balance Sheet
As At 31 October 2025
Balance Sheet
Registered number: 16042321

| 2025
--- | ---
|  | £
Current assets |  | 1,734
Creditors: Amounts Falling Due Within One Year |  | (1,419 )
NET CURRENT ASSETS |  | 315
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 315
Accruals and deferred income |  | (252 )
NET ASSETS |  | 63
CAPITAL AND RESERVES |  | 63

## Notes

1. General Information
HD Clinical Solutions Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16042321 . The registered office is 50-52 Bridge Road, Litherland, Liverpool, L21 6PH.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Mr Hytham Dafalla Director
13th April 2026